Sartorius– tag –
-
Lonza, Sartorius, and FUJIFILM Diosynth Bolster Biopharmaceutical Manufacturing Capacity, Highlighting Single-Use Technology as Key
SNS Insider Unknown Overview This article highlights the biopharmaceutical manufacturing capacity expansions by Lonza Group, Sartorius, and FUJIFILM Diosynth Biotechnologies, as noted in the "Biopharmaceutical Fermentation Market" report... -
Sartorius Unveils AI-Enabled Ambr 250 HT and Pionic Platform, Sustains Strong H1 2026 Business Growth and Profitability
boerse.de Germany Overview Sartorius Stedim Biotech has expanded its solution portfolio with the launch of the AI-enabled Ambr 250 HT Cell Therapies Vessel and the Pionic platform for intensified continuous bioprocessing. These innovatio... -
Sartorius Stedim Ambr 15 24-Vessel Microbioreactor System Accelerates Microbial Fermentation Development with Integrated High-Throughput Analysis Module
Boston Industries USA Overview The Sartorius Stedim Ambr 15 Microbioreactor System enables high-throughput, parallel bioprocess development for microbial fermentation studies, featuring 24 disposable stirred-tank vessels with an integrat... -
Sartorius Drives Bioprocessing Evolution: New Ambr 250 HT and Pionic Modules Fast-Track Cell Therapies and Continuous Manufacturing
Sartorius boerse.de Investing.com Germany Overview Sartorius reported strong H1 2026 growth, largely fueled by new innovations in its Bioprocess Solutions Division. Key launches include the Ambr 250 HT Cell Therapies Vessel, designed for... -
Reusable Bioreactor Market Surges: Driven by Large-Volume Biologics Production and CDMO Capacity Expansion, Hybrid Manufacturing Emerges
Constancy Researchers USA Overview The reusable bioreactor market is experiencing substantial growth, propelled by the increasing demand for large-volume commercial biopharmaceutical production and the expansion of CDMO capacities. A not... -
Sartorius Accelerates Cell & Gene Therapy Commercialization with Comprehensive End-to-End Solutions
Sartorius Germany Overview Sartorius emphasizes its mission to accelerate the commercialization of cell and gene therapies (CGT) by providing end-to-end solutions that deliver reproducible performance and scalability. Its portfolio suppo... -
Sartorius Unveils Next-Gen Lab Balance ‘Cubis III,’ Enhancing Data Integrity with 21 CFR Part 11 Compliance
Chromatography Online USA Overview Sartorius has launched 'Cubis III,' its latest generation of laboratory balances, offering direct embedded connectivity to digital environments, eliminating the need for middleware and significantly red... -
U.S. Stem Cell Manufacturing Market Forecast to Reach $4.04 Billion, Driven by Innovative Technologies and Automation from Thermo Fisher, Lonza, and Sartorius
openPR.com USA Overview This article summarizes a report on the U.S. stem cell manufacturing market, projected to reach $4.04 billion, driven by innovative technologies and strategic initiatives from key players. Thermo Fisher Scientific... -
Sartorius Revolutionizes Protein Production with Rational CHO Host Cell Engineering: Maximizing Intrinsic Expression Capacity
BioProcess International (Sartorius) Germany Overview Sartorius presented a webcast on rational CHO (Chinese Hamster Ovary) host cell engineering, aiming to significantly boost protein production. Diverging from traditional optimization ... -
Frontiers Reports VR-Based Bioreactor Developed for Biomanufacturing and Environmental Engineering Labs: Enhancing Student Education and Access to High-Cost Equipment
Frontiers in Education Switzerland Overview A study published in Frontiers in Education describes the development of a virtual reality (VR)-based bioreactor for biomanufacturing and environmental engineering labs. Modeled after a detaile...
12